Last reviewed · How we verify
NCT07042789
Perception of Health Promotion Messages
NA trial testing Material source: AI generated ads vs existing ads by health agency in Perception of Vaping in 763 participants. Completed in 20 November 2024.
20 November 2024
Quick facts
| Lead sponsor | The University of Queensland |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 763 |
| Start date | 24 August 2024 |
| Primary completion | 20 November 2024 |
| Estimated completion | 20 November 2024 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- Material source: AI generated ads vs existing ads by health agency
- source labelling conditions: control condition, AI condition, health agency condition, combined condition
Conditions studied
- Perception of Vaping — all drugs for Perception of Vaping →
Sponsor
The University of Queensland
Who can join
Adults 16 to 25, any sex, with Perception of Vaping. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The specific aims of this study are: 1. To compare the perceived message effectiveness (PME) of AI-generated vaping prevention materials with existing traditionally generated (typically by a health authority) prevention materials in a sample of young people. This aim addresses the gap in understanding whether AI can match or exceed the effectiveness of traditional prevention materials in changing youth perceptions and intentions of vaping. 2. To examine the impact of ad labelling (AI-generated, AI-generated with health authority endorsement, and unlabelled) on the PME of vaping prevention messages. Given the novelty of AI in this context, understanding the influence of transparency about message origin and endorsements on message reception is critical.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Generative Artificial Intelligence With Youth Codesign to Create Vaping Awareness Advertisements.
Leung J, Sun T, Stjepanovic D, Vu G, et al · · 2025 · cited 1× · PMID 40742592 · DOI 10.1001/jamanetworkopen.2025.14040
Verify or expand the search:
- PubMed search for NCT07042789
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The University of Queensland trials
Trials by the same sponsor.
- NCT06120673 — REmission in Membranous Nephropathy International Trial (REMIT) · Phase 3 · withdrawn
- NCT06642597 — STarting incrEmental Prescription of Peritoneal Dialysis · NA · recruiting
- NCT07114354 — Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Diseas · NA · not yet recruiting
- NCT06806709 — Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial) · NA · recruiting
- NCT06882239 — SPINEPASS: SPINE Self-management Techniques for Persistent Headache After Concussion: Physical Therapy Targeting Autonom · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07042789 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Queensland
- Last refreshed: 29 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07042789.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing